XML 21 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 119,084 $ 134,466
Restricted cash 10,718 0
Short-term investments 37,090 58,558
Accounts receivable 37,550 20,168
Deferred income taxes 1,161 1,161
Prepaid expenses and other current assets 5,146 4,355
Total current assets 210,749 218,708
Property and equipment, net of accumulated depreciation and amortization 374 500
Patents, net of accumulated amortization 262,337 286,636
Goodwill 30,149 30,149
Other assets 355 355
Total assets 503,964 536,348
Current liabilities:    
Accounts payable and accrued expenses 11,525 14,860
Accrued patent investment costs 0 16,700
Royalties and contingent legal fees payable 20,181 14,351
Total current liabilities 31,706 45,911
Deferred income taxes 1,161 1,161
Other liabilities 271 228
Total liabilities $ 33,138 $ 47,300
Commitments and contingencies (Note 5)    
Stockholders' equity:    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding $ 0 $ 0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,979,582 and 50,065,382 shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively 51 50
Treasury stock, at cost, 1,729,408 shares as of June 30, 2015 and December 31, 2014 (34,640) (34,640)
Additional paid-in capital 641,207 646,595
Accumulated comprehensive loss (413) (353)
Accumulated deficit (144,911) (128,095)
Total Acacia Research Corporation stockholders' equity 461,294 483,557
Noncontrolling interests in operating subsidiaries 9,532 5,491
Total stockholders' equity 470,826 489,048
Total liabilities and stockholders' equity $ 503,964 $ 536,348